In various experimental settings, IL-6, TNF-α, and IL-1β were found to induce proliferative and secretory BC activities as well as affect stem-like properties that differed between HER2-negative and HER2-positive BC clones [23,50]. Here, ERBB2 is linked to breast cancer.